Healthverity

OverviewSuggest Edit

HealthVerity is developing an important set of proprietary technologies and software tools that enable its customers, including pharmaceutical manufacturers, hospitals and health insurers, and healthcare technology suppliers to rapidly discover, license and assemble patient data from a wide range of traditional and emerging healthcare data sources. The company’s solutions are targeted toward enhancing the ability of organizations to generate new patient insights from existing and new healthcare data sources.

TypePrivate
Founded2014
HQPhiladelphia, PA, US
Websitehealthverity.com
Employee Ratings5

Latest Updates

Employees (est.) (Mar 2021)119
Cybersecurity ratingAMore

Key People/Management at Healthverity

Andrew Kress

Andrew Kress

Co-Founder and CEO
Amanda Elefante

Amanda Elefante

VP, People
Austin Eliazar

Austin Eliazar

Chief Data Scientist
Tara Harding

Tara Harding

VP, Revenue Operations
Dominique Hurley

Dominique Hurley

VP, Strategy & Innovation
David Pinski

David Pinski

VP, Product Management
Show more

Healthverity Office Locations

Healthverity has an office in Philadelphia
Philadelphia, PA, US (HQ)
1818 Market Street, 1818 Market St #200
Show all (1)

Healthverity Financials and Metrics

Summary Metrics

Founding Date

2014

Healthverity total Funding

$42.2 m

Healthverity latest funding size

$25 m

Time since last funding

2 years ago

Healthverity investors

Healthverity's latest funding round in April 2019 was reported to be $25 m. In total, Healthverity has raised $42.2 m
Show all financial metrics

Healthverity Cybersecurity Score

Cybersecurity ratingPremium dataset

A

90/100

SecurityScorecard logo

Healthverity Online and Social Media Presence

Embed Graph

Healthverity News and Updates

Ciox Health and HealthVerity Announce Partnership to Enable First-in-Kind Decentralized Clinical Trial

ALPHARETTA, Ga., Feb. 10, 2021 /PRNewswire/ -- Ciox Health, a leading health technology company, today announced a strategic collaboration between its Real World Data (RWD) Division and HealthVerity, the leader in privacy-protected data exchange. By pairing HealthVerity's real-world data...

HealthVerity Awarded U.S. Patent for Privacy-Preserving Analysis for Secure Multi-Party Computing

PHILADELPHIA, Dec. 9, 2020 /PRNewswire/ -- HealthVerity, the leader in privacy-protected data exchange, announced today that the U.S. Patent and Trademark Office ("USPTO") issued U.S. Pat. No. 10,824,738 on November 3, 2020 in support of HealthVerity's privacy-preserving technology that...

HealthVerity and Medidata Announce Strategic Partnership to Advance Real World Evidence During and After Clinical Trials

PHILADELPHIA, Nov. 20, 2020 /PRNewswire/ -- HealthVerity, the leader in privacy-protected data exchange, today announced a strategic collaboration with Medidata, a Dassault Systèmes company, the global leader in creating end-to-end solutions to support the entire clinical development...

HealthVerity Joins Accenture's INTIENT Network to Help Drive Innovation in Drug Discovery, Scientific Research and Improve Patient Outcomes

PHILADELPHIA, Nov. 18, 2020 /PRNewswire/ -- HealthVerity, a leader in privacy-protected data exchange, has joined the INTIENT Network ecosystem which is designed to help independent software vendors (ISV) and life sciences companies collaborate more effectively to accelerate drug...

HealthVerity launches an integrated cloud platform designed to revolutionize how healthcare enterprises approach data strategy

PHILADELPHIA, Nov. 16, 2020 /PRNewswire/ -- HealthVerity, the leader in privacy-protected data exchange, today announced the commercial availability of its integrated cloud platform offering flexible technologies that empower healthcare enterprises to design and build their own unique...

HealthVerity launches Provider Diversity Index to accelerate recruitment of minority groups into clinical trials

PHILADELPHIA, Aug. 26, 2020 /PRNewswire/ -- HealthVerity, the leader in privacy-protected data exchange, today expanded its commitment to advancing racial and ethnic diversity and inclusion in clinical trials with the launch of the "Provider Diversity Index." With more than 330 million...
Show more

Healthverity Blogs

How RWE can support drug development during COVID-19 and beyond: Q&A with Dr. Diana Brainard of Gilead Sciences

The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many adapted their clinical trial operations while working to develop lifesaving interventions. At Gilead Sciences, this need to quickly pivot led to an increased understanding of how real-world evid…

Covid-19 antibodies may protect against reinfection later, study suggests

CNN The post Covid-19 antibodies may protect against reinfection later, study suggests appeared first on HealthVerity.

NCI study finds that people with SARS-CoV-2 antibodies may have a low risk of future infection

National Cancer Institute The post NCI study finds that people with SARS-CoV-2 antibodies may have a low risk of future infection appeared first on HealthVerity.

The role of RWE: Longitudinal patient insights bridging clinical and real-word data

COVID-19 has heightened the need for an expanded understanding of clinical trial populations and patient insights both during and post-trial. With more immediate access to real-world data, clinical trial design, study effectiveness and real-time research can improve drastically. 

2021 Data Imperatives: The pulse of the industry

The healthcare industry relies on real-world data more and more to make informed and effective decisions and the COVID-19 pandemic has highlighted this need more than ever. 2020 has proven that centralized data management, a greater ability to share and exchange data and advanced technol…

SARS-CoV-2 Antibodies Can Protect from Reinfection, NCI Study Suggests

The National Cancer Institute The post SARS-CoV-2 Antibodies Can Protect from Reinfection, NCI Study Suggests appeared first on HealthVerity.
Show more

Healthverity Frequently Asked Questions

  • When was Healthverity founded?

    Healthverity was founded in 2014.

  • Who are Healthverity key executives?

    Healthverity's key executives are Andrew Kress, Amanda Elefante and Austin Eliazar.

  • How many employees does Healthverity have?

    Healthverity has 119 employees.

  • Who are Healthverity competitors?

    Competitors of Healthverity include PinnacleCare, Verilogue and eClinicalWorks.

  • Where is Healthverity headquarters?

    Healthverity headquarters is located at 1818 Market Street, 1818 Market St #200, Philadelphia.

  • Where are Healthverity offices?

    Healthverity has an office in Philadelphia.

  • How many offices does Healthverity have?

    Healthverity has 1 office.